Journey in reverse: TTP from bedside to blood bank to bench

Journal of Clinical Apheresis - Tập 22 Số 1 - Trang 37-49 - 2007
Joel L. Moake1
1Baylor College of Medicine and Rice University, Houston, Texas

Tóm tắt

AbstractThrombotic thrombocytopenic purpura (TTP) is the most extensive and dangerous intravascular platelet clumping disorder. For more than a half‐century after its initial recognition, mortality was near 100% and the etiology totally obscure. Then, in the late 1970s to early 1980s, empiric, but successful, therapy by a few clinician/blood bank partnerships was followed by sudden laboratory insight into pathophysiology. The discussion that follows was prepared in conjunction with the 2006 Francis Morrison, M.D., Memorial Lecture at the 27th Annual Meeting of the American Society for Apheresis. J. Clin. Apheresis. © 2006 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

Marcus A, 1992, Hemolytic uremic syndrome and thrombotic thromboctyopenic purpura, 19

Moschcowitz E, 1924, Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease, Proc NY Pathol Soc, 24, 21

10.1001/archinte.1925.00120130092009

Baehr G, 1936, An acute febrile anemia and thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles, Trans Assoc Am Phys, 65, 45

Harkness D, 1981, Hazard of platelet transfusion in thrombotic thrombocytopenic purpura, J Am Med Assoc, 246, 1931, 10.1001/jama.1981.03320170043028

10.1016/0049-3848(85)90180-X

10.1136/bmj.2.4790.897

10.1111/j.1365-2141.1962.tb06541.x

10.1097/00005792-196603000-00003

Bukowski RM, 1976, Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura, Semin Hematol, 13, 219

10.1002/ajh.2830030109

10.1056/NEJM197712222972507

10.1056/NEJM197806152982407

Bukowski RM, 1982, Thrombotic thrombocytopenic purpura: a review, Progr Hemost Thromb, 6, 287

10.1055/s-2007-1005062

10.1182/blood.V50.3.413.413

10.1056/NEJM199108083250605

10.1056/NEJM199108083250604

10.1056/NEJM198212023072306

Schulman I, 1960, Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency, Blood, 16, 943, 10.1182/blood.V16.1.943.943

Moake JL, 1985, Effects of fresh‐frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 65, 1232, 10.1182/blood.V65.5.1232.1232

Frangos JA, 1989, Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells, Am J Physiol, 256, H1635

Moake J, 1994, Solvent/detergent‐treated plasma suppresses shear‐induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura, Blood, 84, 490, 10.1182/blood.V84.2.490.490

10.1172/JCI112736

10.1182/blood-2002-05-1401

Furlan M, 1997, Deficient activity of von Willegrand factor‐cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097

Furlan M, 1998, Acquired deficiency of von Willebrand factor‐cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839, 10.1182/blood.V91.8.2839.2839_2839_2846

10.1056/NEJM199811263392202

10.1056/NEJM199811263392203

10.1182/blood.V98.6.1662

10.1074/jbc.C100515200

10.1038/35097008

10.1056/NEJMra020528

10.1182/blood-2002-02-0344

10.1182/blood-2003-01-0193

10.1182/blood.V98.6.1765

10.1182/blood-2003-11-4035

10.1182/asheducation-2004.1.407

10.1203/00006450-200105000-00008

10.7326/0003-4819-128-7-199804010-00004

10.1056/NEJM200006153422402

Rabadi SJ, 1982, Mitomycin‐induced hemolytic uremic syndrome: case presentation and review of literature, Cancer Treat Rep, 66, 1244

10.1111/j.1365-2141.1983.tb02067.x

10.1002/(SICI)1096-8652(199608)52:4<310::AID-AJH11>3.0.CO;2-H

10.1002/ajh.2830420306

10.1111/j.1432-2277.1996.tb00855.x

10.1016/S0889-8588(05)70348-8

10.1097/00001813-200311000-00009

10.7326/0003-4819-135-12-200112180-00008

Gottschall JL, 1991, Quinine‐induced immune thrombocytopenia associated with hemolytic‐uremic syndrome: a new clinical entity, Blood, 77, 306, 10.1182/blood.V77.2.306.306

10.1002/cncr.20290

Byrnes JJ, 1986, Thrombotic thrombocytopenic purpura and the hemolytic‐uremic syndrome: evolving concepts of pathogenesis and therapy, Clinics Haematol, 15, 413, 10.1016/S0308-2261(18)30024-9

10.1016/S0140-6736(94)91227-0

10.1111/j.1537-2995.2004.00626.x

10.1046/j.1537-2995.2002.00100.x

van der Plas RM, 1999, von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation‐associated thrombotic thrombocytopenic purpura, Blood, 93, 3798, 10.1182/blood.V93.11.3798

10.4065/78.4.421

Ruggeri ZM, 2000, Developing basic and clinical research on von Willebrand factor and von Willebrand disease, Thromb Haemost, 84, 147, 10.1055/s-0037-1613989

10.1182/blood-2001-11-0060

10.1182/blood.V71.5.1366.1366

10.1182/blood.V83.8.2171.2171

Tsai HM, 1996, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its confirmation and requires calcium ion, Blood, 87, 4235, 10.1182/blood.V87.10.4235.bloodjournal87104235

10.1182/blood.V87.10.4223.bloodjournal87104223

10.1074/jbc.M301385200

10.1182/blood-2003-08-2956

10.1182/blood-2004-01-0107

10.1182/blood-2005-05-2111

Bork P, 1993, The CUB domain ‐ a widespread module in developmentally regulated proteins, J Mo Biol, 231, 530

10.1182/blood-2005-01-0152

10.1038/labinvest.3700275

10.1046/j.1365-2141.2001.02808.x

10.1021/bi0204692

10.1182/blood-2005-05-2029

10.1074/jbc.M502529200

10.1073/pnas.0402041101

10.1111/j.1538-7836.2005.01122.x

Moake JL, 1989, Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and hemolytic‐uremic syndrome, Am J Med, 87, 9N

10.1002/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P

10.1055/s-0037-1614408

10.1111/j.1365-2141.2000.02503.x

10.1182/blood-2003-04-1346

10.1053/j.seminhematol.2003.10.005

10.7326/0003-4819-132-10-200005160-00005

10.1182/blood-2003-12-4165

10.1074/jbc.M309872200

Oleksowicz L, 1999, Deficient activity of von Willebrand's factor‐cleaving protease in patients with disseminated malignancies, Cancer Res, 59, 2244

10.1182/blood-2004-03-1101

10.1182/blood-2005-03-1087

10.1182/blood.V98.9.2730

10.1182/blood-2005-03-1087

10.1093/infdis/151.5.775

10.1385/MB:26:2:117

10.1111/j.0958-7578.2004.00478.x

10.1002/ajh.2830340303

10.1002/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z

Abassi E, 2004, Correlation of ADAMTS‐13 activity with response to plasma exchange in patients diagnosed with thrombotic thrombocytopenic purpura, Blood, 104, 242a

10.1006/bcmd.2002.0522

10.1002/ajh.10204

10.1182/blood.V83.2.435.435

10.1034/j.1600-0609.2003.00026.x

10.7326/0003-4819-138-2-200301210-00011

Thompson CE, 1992, Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic, Blood, 80, 1890, 10.1182/blood.V80.8.1890.bloodjournal8081890

10.7326/0003-4819-125-4-199608150-00006

Kremer Hovinga JA, 2004, Splenectomy in relapsing and plasma‐refractory acquired thrombotic thrombocytopenic purpura, Haematologica, 89, 320

Gordon LI, 1987, Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy, Semin Hematol, 24, 194

10.1002/jca.20007

10.1182/blood-2002-05-1397

10.1074/jbc.M504919200